These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20156065)

  • 21. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.
    Landman D; Kelly P; Bäcker M; Babu E; Shah N; Bratu S; Quale J
    J Antimicrob Chemother; 2011 Feb; 66(2):332-4. PubMed ID: 21131322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
    Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
    Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
    Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens.
    Jean SS; Hsueh PR
    Expert Opin Pharmacother; 2011 Oct; 12(14):2145-8. PubMed ID: 21895553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
    Haeili M; Ghodousi A; Nomanpour B; Omrani M; Feizabadi MM
    J Infect Dev Ctries; 2013 Apr; 7(4):312-7. PubMed ID: 23592640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain.
    Ko WC; Lee HC; Chiang SR; Yan JJ; Wu JJ; Lu CL; Chuang YC
    J Antimicrob Chemother; 2004 Feb; 53(2):393-5. PubMed ID: 14729739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel β-Lactam Enhancer Zidebactam Augments the
    Bhagwat SS; Periasamy H; Takalkar SS; Palwe SR; Khande HN; Patel MV
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
    Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
    J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.
    Bui KQ; Banevicius MA; Nightingale CH; Quintiliani R; Nicolau DP
    J Antimicrob Chemother; 2000 Jan; 45(1):57-62. PubMed ID: 10629013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.